Search

everythinglearnresearchcommunity

for

Search:↓

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Upadacitinib improved multiple immune-related conditions in one patient.

Nilotinib can cause keratosis pilaris, a skin condition.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

The treatment combination is effective and generally safe for lung cancer.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

A3B5 can reduce skin pigmentation and slow melanoma growth.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Bortezomib chemotherapy can cause temporary skin rashes.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Abrocitinib may effectively treat Lichen Planopilaris.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.